Columbus Venture Partners (VP) has closed on Tuesday its fourth investment fund with a size of 150 million euros for startups in the biotechnology and pharmaceutical sector, while the total amount of ...
ARTHEx Biotech has announced that the U.S. Food and Drug Administration (FDA) cleared the Company to initiate the Phase I-IIa ArthemiR™ study of ATX-01 for the treatment of Myotonic Dystrophy Type 1...
Quatre Lab, una empresa vasca especializada en servicios de Control de Calidad para terapias avanzadas y respaldada por Columbus Venture Partners, lidera un sindicato de inversores que incluye a Accor...
The investors behind QUATRE LAB include Columbus Venture Partners through its Columbus Life Sciences Fund III and Gestión de Capital Riesgo del País Vasco, SGEIC, S.A. – Grupo SPRI, through its ma...
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs announced the closing of its €42 million Series B financing...
Columbus Life Sciences Fund IV has been recently incorporated and accepted by the CNMV. CVP's fund IV will have a size of EUR 150 million and will follow the same strategy as the previous funds. 10 - ...
Cocoon Bioscience’s funding round, led by Columbus Venture Partners and Cleon Capital, will also include several blue-chip co-investors including the Spanish listed company Viscofan, US-based North ...
Minoryx is backed by a syndicate of experienced investors, which includes Columbus Venture Partners, CDTI Innvierte, Caixa Capital Risc, Fund+, Ysios Capital, Roche Venture Fund, Kurma Partners, Chies...
The shareholders of Algenex, a privately held biotechnology company backed by a group of families advised by Cleon Capital and leading Spanish biotech fund Columbus Venture Partners, today announced a...
Integra Therapeutics, a biotechnology company that creates next generation gene writing tools, has closed an additional €1.5-million investment from venture capital firm Columbus Venture Partners. T...
Damià Tormo, Managing Partner de Columbus Venture Partners: “El equipo de Sanifit ha conseguido llevar un proyecto de investigación desde la investigación básica de la Universidad de Islas Balea...